Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Stroke. 2015 Aug 4;46(9):2529–2533. doi: 10.1161/STROKEAHA.115.010260

Table 2. Patient Characteristics (N=27).

Age, median (range) 73.4 (34.0, 85.7)
Male, N (%) 13 (48%)
Black, N (%) 4 (15%)
Hispanic (%) 1 (4%)
Baseline NIHSS, median (range) 12 (6, 26)
Pre-stroke mRS, N (%)
 0 17 (63%)
 1 1 (4%)
 2 1 (4%)
 3 7 (26%)
 4 1 (4%)
Time from stroke onset to IV rt-PA (minutes), median (range) 118 (71, 182)
Time from start of IV rt-PA to start of eptifibatide (minutes), median (range) 37 (15, 57)
Medical History, N (%)
 Atrial Fibrillation 12 (44%)
 Hypertension 20 (74%)
 Diabetes 11 (41%)
 Congestive heart failure 4 (15%)
 Myocardial infarction 6 (22%)
 Hyperlipidemia 18 (67%)
 Prior stroke 7 (26%)

Data presented as Median (minimum, maximum) or n (%)